Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

Thursday, January 12, 2017

Maverick Therapeutics Inc an MPM Capital portfolio company and Takeda Pharmaceutical Company Limited announced today that they have entered a collaboration to develop Mavericks Tcell engagement platform created specifically to improve the utility of...

Valeant Pharmaceuticals To Sell Dendreon To Sanpower Group For $819.9 Million

Wednesday, January 11, 2017

Valeant Pharmaceuticals International Inc announced that its affiliate has entered into a definitive agreement to sell all of the outstanding equity interests in Dendreon Pharmaceuticals Inc Dendreon to the Sanpower Group Co Ltd one of the largest pr...

Chi-Med Initiates HMPL-523 Clinical Trials in Hematological Cancer in China

Wednesday, January 11, 2017

Hutchison China MediTech Limited announces that it has initiated a Phase I trial of its novel spleen tyrosine kinase Syk inhibitor HMPL in patients with hematological malignancies in China The first patient was dosed on December This study compleme...

ViraCyte Granted U.S. FDA Fast Track Designation for Viralym-C

Wednesday, January 11, 2017

ViraCyte LLC announced that the US Food and Drug Administration FDA has granted Fast Track designation for ViralymC ViraCytes T cell immunotherapy product designed to treat refractory cytomegalovirus CMV infections in patients following a stem cell t...

Pure MHC to Partner with AbbVie on Oncology Research

Tuesday, January 10, 2017

Emergent Technologies Inc ETI announced that its target discovery portfolio company Pure MHC and global biopharmaceutical company AbbVie NYSEABBV will embark on a research and license agreement to discover and validate peptide targets for use with Tc...

Takeda to Acquire ARIAD Pharmaceuticals, Inc. for $5.2 Billion

Tuesday, January 10, 2017

Takeda Pharmaceutical Company Limited and ARIAD Pharmaceuticals Inc announced that they have entered into a definitive agreement under which Takeda will acquire all of the outstanding shares in ARIAD for per share in cash or an enterprise value of a...

Zebra Biologics Inc. to Collaborate with AbbVie to Discover New Antibody Therapeutics

Tuesday, January 10, 2017

Zebra Biologics Inc an emerging preclinical stage biotechnology company announced that the company has entered into a collaboration with AbbVie to discover agonist antibody therapeutics for inflammatory diseases Zebra will use its novel and patented...

Enzyvant to Develop Novel Biologic Therapy for Complete DiGeorge Syndrome

Monday, January 09, 2017

Enzyvant a biopharmaceutical company focused on developing innovative treatments for patients with rare diseases today announced entering into an exclusive worldwide licensing agreement with Duke University to develop RVT a tissuebased therapy for th...

Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals

Monday, January 09, 2017

Ipsen today announced that it has entered into a definitive agreement to acquire global oncology assets from Merrimack Pharmaceuticals including its key marketed product ONIVYDE irinotecan liposome injection for the treatment of patients with metasta...

Mast Therapeutics And Savara Sign Merger Agreement

Saturday, January 07, 2017

Mast Therapeutics Inc and Savara Inc a privatelyheld emerging specialty pharmaceutical company focused on the treatment of rare respiratory diseases today announced that the two companies have entered into a definitive merger agreement under which th...